Suppr超能文献

经腹与腹膜后腹腔镜肾上腺切除术治疗巨大嗜铬细胞瘤:比较结果

Transperitoneal versus retroperitoneal laparoscopic adrenalectomy for large pheochromocytoma: Comparative outcomes.

作者信息

Shiraishi Koji, Kitahara Seiji, Ito Hideaki, Oba Kazuo, Ohmi Chietaka, Matsuyama Hideyasu

机构信息

Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan.

Department of Urology, Sanyo-Onoda Municipal Hospital, Yamaguchi, Japan.

出版信息

Int J Urol. 2019 Feb;26(2):212-216. doi: 10.1111/iju.13838. Epub 2018 Nov 14.

Abstract

OBJECTIVES

To evaluate operative and oncological outcomes of laparoscopic adrenalectomy through a transperitoneal approach and retroperitoneal approach for large (>5 cm in diameter) pheochromocytomas.

METHODS

We retrospectively compared the results of a transperitoneal approach with those of a retroperitoneal approach in 22 patients (mean age 57.5 years, range 38-76 years) with unilateral large pheochromocytomas (12 right, 10 left). The mean body mass index, operation time, pneumoperitoneum time, estimated blood loss, fluctuation in blood pressure and complication rate were compared between the two approaches.

RESULTS

The mean tumor diameter (range) was 7.0 cm (range 5.2-15.5 cm), and no significant differences were observed between the transperitoneal approach and retroperitoneal approach in any baseline clinical parameter. For right-sided procedures, significant differences were found for operation time (113 vs 85 min), pneumoperitoneum time (93 vs 64 min) and estimated blood loss (96 vs 23 mL; P < 0.05, transperitoneal approach and retroperitoneal approach, respectively). No open conversion or recurrence was reported, but one right transperitoneal approach case required blood transfusion. No difference in these parameters was noted on the left side.

CONCLUSIONS

For right side procedures, the retroperitoneal approach is feasible, safer and faster than the transperitoneal approach for large pheochromocytomas. Early transection of the feeding artery is beneficial for managing the tumor and reducing the risk of bleeding.

摘要

目的

评估经腹腔途径和经腹膜后途径腹腔镜肾上腺切除术治疗直径大于5厘米的嗜铬细胞瘤的手术及肿瘤学结局。

方法

我们回顾性比较了22例单侧大嗜铬细胞瘤(右侧12例,左侧10例)患者(平均年龄57.5岁,范围38 - 76岁)经腹腔途径与经腹膜后途径的手术结果。比较了两种途径的平均体重指数、手术时间、气腹时间、估计失血量、血压波动及并发症发生率。

结果

平均肿瘤直径(范围)为7.0厘米(范围5.2 - 15.5厘米),经腹腔途径与经腹膜后途径在任何基线临床参数上均未观察到显著差异。对于右侧手术,在手术时间(113对85分钟)、气腹时间(93对64分钟)和估计失血量(96对23毫升;P < 0.05,分别为经腹腔途径和经腹膜后途径)方面发现了显著差异。未报告中转开腹或复发情况,但1例经腹腔途径右侧手术患者需要输血。左侧手术在这些参数上未发现差异。

结论

对于右侧手术,经腹膜后途径治疗大嗜铬细胞瘤比经腹腔途径更可行、更安全且更快。早期切断供血动脉有利于处理肿瘤并降低出血风险。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验